Form SCHEDULE 13G/A Olema Pharmaceuticals, Filed by: Bain Capital Life Sciences Opportunities IV, L.P. May 15, 2026 04:35PM
Form SCHEDULE 13G/A Olema Pharmaceuticals, Filed by: Bain Capital Life Sciences Opportunities IV, L.P. Feb 17, 2026 04:31PM
Form SCHEDULE 13G/A Olema Pharmaceuticals, Filed by: Bain Capital Life Sciences Opportunities IV, L.P. May 15, 2025 07:00AM
Form 4 Olema Pharmaceuticals, For: Jan 08 Filed by: Bain Capital Life Sciences Fund IV, L.P. Jan 13, 2025 04:35PM
Form 3 Olema Pharmaceuticals, For: Jan 08 Filed by: Bain Capital Life Sciences Fund IV, L.P. Jan 13, 2025 04:32PM


Jan 13, 2025 04:25PM Form SCHEDULE 13G/A Olema Pharmaceuticals, Filed by: Bain Capital Life Sciences Opportunities IV, L.P.
Dec 11, 2024 04:30PM Form SC 13G Olema Pharmaceuticals, Filed by: Bain Capital Life Sciences Opportunities IV, L.P.
Dec 2, 2024 07:33AM Olema Pharmaceuticals (OLMA) Announces New Clinical Trial Collaboration and Supply Agreement with Novartis in Frontline Metastatic Breast Cancer as well as $250 Million Equity Private Placement